Drug
MET097
MET097 is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
2
50%
Ph phase_3
1
25%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Active, not recruiting2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)
Trials by Status
active_not_recruiting250%
recruiting125%
completed125%
Recent Activity
3 active trials
Showing 4 of 4
active_not_recruitingphase_3
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
NCT07311850
recruitingphase_1
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
NCT06924320
active_not_recruitingphase_2
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight
NCT06973720
completedphase_2
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight
NCT06712836
Clinical Trials (4)
Showing 4 of 4 trials
NCT07311850Phase 3
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
NCT06924320Phase 1
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
NCT06973720Phase 2
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight
NCT06712836Phase 2
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4